Deals

Best Dental in Richmond, Texas Joins Pearl Street Dental Partners, a Family-Style Dental Group

Best Dental, the Richmond family practice run by Dr. Jasmine Naderi and her brother Dr. Sonny Naderi, has joined Pearl Street Dental Partners. Pearl Street is a dental group based in Dallas that works with practices across Texas and Oklahoma. Pearl Street was started in 1999 by Dr. Robby Jennings and David Meece. The group […]

Best Dental in Richmond, Texas Joins Pearl Street Dental Partners, a Family-Style Dental Group Read More »

Sabra Health Care REIT, Landmark Recovery Call It Quits in Court

A court-approved settlement agreement between Landmark Recovery and Sabra Health Care REIT (Nasdaq: SBRA) will see the two entities part ways after a years-long partnership. The separation of the two organizations extends to all of the facilities that Landmark Recovery holds leases for with Sabra Health Care REIT. The deal will require Landmark Recovery to

Sabra Health Care REIT, Landmark Recovery Call It Quits in Court Read More »

Cushman & Wakefield Brokers Sale of MedStar Montgomery Medical Center I and II in Olney, Md.

Cushman & Wakefield (NYSE: CWK) a leading global real estate services firm, announces it brokered the sale of MedStar Montgomery Medical Center I and II, a two-building, 127,868-square-foot on-campus medical office portfolio monetization in Olney, Md., a northern suburb of Washington, D.C. The portfolio, situated at 18109 and 18111 Prince Philip Drive, was approximately 95%

Cushman & Wakefield Brokers Sale of MedStar Montgomery Medical Center I and II in Olney, Md. Read More »

Thermo Fisher Scientific Signs Agreement to Sell Its Microbiology Business to Astorg

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announces that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing

Thermo Fisher Scientific Signs Agreement to Sell Its Microbiology Business to Astorg Read More »

Invidia Capital Management to Make Growth Capital Investment in WIN, a Leading Fertility and Family-Building Benefits Platform

Invidia Capital Management announces the signing of a definitive agreement under which Invidia will make a growth investment in WIN Holding Corporation, a leading provider of fertility and family support benefit services. WIN is a women’s health company offering services across fertility treatment and preservation, surrogacy and adoption, maternity, menopause, and return-to-work programs. Led by

Invidia Capital Management to Make Growth Capital Investment in WIN, a Leading Fertility and Family-Building Benefits Platform Read More »

vVARDIS Announces Investment from Apollo

vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, announces a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few

vVARDIS Announces Investment from Apollo Read More »

Provident Healthcare Partners Advises Avecina Medical in Its Acquisition by MD Now Urgent Care

Provident Healthcare Partners (“Provident”), a leading healthcare investment banking firm, announced it has advised Avecina Medical (“Avecina”), an operator of 18 urgent care centers in Jacksonville and Central Florida, in its acquisition by MD Now Urgent Care, an affiliate of HCA Healthcare (“HCA”). The acquisition expands MD Now’s footprint to over 110 Florida locations. “It

Provident Healthcare Partners Advises Avecina Medical in Its Acquisition by MD Now Urgent Care Read More »

Sun Pharma Signs Definitive Agreement to Acquire Organon

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) announce that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in

Sun Pharma Signs Definitive Agreement to Acquire Organon Read More »

Lilly to Acquire Ajax Therapeutics to Advance Outcomes for Patients with Myelofibrosis and Polycythemia Vera

Eli Lilly and Company (NYSE: LLY) and Ajax Therapeutics, Inc. (“Ajax”), a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), announce a definitive agreement for Lilly to acquire Ajax. Ajax’s lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-class Type II JAK2 inhibitor currently being evaluated in a Phase 1

Lilly to Acquire Ajax Therapeutics to Advance Outcomes for Patients with Myelofibrosis and Polycythemia Vera Read More »

Johnson & Johnson Enters Agreement to Acquire Atraverse Medical

Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire Atraverse Medical, Inc., a privately-held medical device company pioneering next-generation left-heart access and radiofrequency (RF) technology. Achieving safe and precise access to the left atrium remains one of the most critical steps in atrial fibrillation ablation. Atraverse Medical’s HOTWIRE™ Transseptal Access System,

Johnson & Johnson Enters Agreement to Acquire Atraverse Medical Read More »

Scroll to Top